IFNAR2 and COVID-19: While IFNAR2 was not measured by the proteomic assays, isoforms of IFNAR2 lacking the transmembrane domain are known to generate a soluble protein isoform43, and significantly higher quantities of soluble IFNAR2 have been observed in the serum of patients with severe COVID-19 (ref. 44).